AesculaTech logo — Building a better world through custom chemistry.

AesculaTech

Building a better world through custom chemistry.

Founded 2016 United States Los Angeles, United States 13 employees Convertible Note Total: $120.00K Biopharma, Biotechnology +2

General Information

Company Name AesculaTech
Founded Year 2016
Location United States Los Angeles, United States
Employees 13
Industries Biopharma, Biotechnology, Manufacturing +1
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with AesculaTech. To contact AesculaTech, visit aesculatech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AesculaTech compare?

A PDF of AesculaTech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AesculaTech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AesculaTech

AesculaTech is a technology startup with a vision to create a product ecosystem driven by materials with a mind of their own, aiming to build a better world through custom chemistry. They are focused on cultivating materials that interface with biological and environmental stimuli for use in biomedical devices, cosmetics, and consumer products. Founded in 2016 and headquartered in the United States, the company is currently concentrating on the late-stage development of a dry eye treatment. Notably, AesculaTech is a graduate of YCombinator and has gained recognition with its CEO featured on MIT Technology Review’s 35 Innovators Under 35. Additionally, the company is advised by scientific and industry leaders. Their most recent investment was a Convertible Note investment on 28 June 2021, and the investor involved was Plug and Play. AesculaTech operates within the Biopharma, Biotechnology, Manufacturing, and Medical Devices industries, showcasing a promising trajectory in the intersection of science and technology.

Business keywords: Biomedical devices, Custom chemistry, Materials engineering, Stimuli-responsive materials, Ocular drug delivery, Medical technology, Cosmeceuticals, Startup accelerators, Innovative therapies, Chemical engineering, Innovative materials, Biomedical engineering

Services & Products

Development of smart materials and products in biomedical
industrial
and cosmetic sectors

Target Customers

Biomedical and cosmetic industries patients requiring innovative medical solutions industrial sectors seeking advanced materials

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Undisclosed 1
Plug and Play
28 Jun 2021
Convertible Note Undisclosed 1
Plug and Play
08 Jul 2020
Convertible Note Undisclosed 1
Plug and Play
09 Apr 2019
Seed Round $120.00K 1
Y Combinator
04 Jan 2018

AesculaTech Alternatives & Competitors

View All Alternatives
AesculaTech vs

Leading The Charge™️

Post-IPO Debt
87 employees
Biotechnology, Health Care
AesculaTech vs

BEAR Implant: The Bridge to ACL Restoration

Series B
73 employees
Biotechnology, Health Care
AesculaTech vs
Vaxxas
Vaxxas Australia

Vaxxas is commercializing novel technology that dramatically enhances the performance of existing an...

Grant
128 employees
Biotechnology, Health Care

FAQ About AesculaTech

Building a better world through custom chemistry.
AesculaTech was founded in 2016.
AesculaTech is headquartered in Los Angeles, United States.
AesculaTech operates in Biopharma, Biotechnology, Manufacturing and Medical Devices. Its work centres on Biomedical devices, Custom chemistry, Materials engineering and Stimuli-responsive materials. Its customers include Biomedical and cosmetic industries, patients requiring innovative medical solutions and industrial sectors seeking advanced materials.
AesculaTech has approximately 13 employees.
AesculaTech has completed 4 funding rounds, raising a total of $120.00K. The latest funding stage is Convertible Note.
AesculaTech offers: Development of smart materials and products in biomedical, industrial, and cosmetic sectors.
Top alternatives and competitors to AesculaTech include Acutus Medical, Inc., Miach Orthopaedics, Inc., Vaxxas, Corpomédica, Fractyl Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AesculaTech and Acutus Medical, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AesculaTech, https://bouncewatch.com/company/aesculatech, updated 24 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes